Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)
NCT01190072 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2013-01-29
Summary
The purpose of the study is to follow the management of blood lipids in patients with planned percutaneous coronary intervention (widening of coronary vessels) in a period from 6 to 10 weeks after the intervention.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Vojko Kanic · University Medical Centre Maribor
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2011-03-31
- Completion
- 2011-03-31
Countries
- Slovenia
Study Locations
More Related Trials
-
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
NCT05457582 ·Status: RECRUITING ·Phase: NA
-
Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins
NCT01047176 ·Status: COMPLETED
-
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
NCT00770575 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Short-term Intensive Statin Therapy on Lipid Levels
NCT07344610 ·Status: RECRUITING
-
The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia
NCT00329069 ·Status: COMPLETED ·Phase: NA
-
Post- Myocardial Infarction Arterial Wall Improvement by Low-dose Fluvastatin and Valsartan
NCT03309618 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.
NCT02400775 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention
NCT06626126 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care
NCT01105325 ·Status: TERMINATED
-
Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease
NCT01041729 ·Status: COMPLETED ·Phase: PHASE4
-
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
NCT00469326 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
NCT00979940 ·Status: TERMINATED ·Phase: NA
-
Effects of Intensive Statin Treatment on Left Ventricular Function
NCT01936103 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI
NCT04754789 ·Status: UNKNOWN ·Phase: PHASE3
-
Pitavastatin on Carotid Intima-media Thickness
NCT00711919 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
NCT04900155 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis
NCT00485121 ·Status: COMPLETED ·Phase: NA
-
Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI
NCT01033058 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimal LDL-C Target in High-risk Patients After PCI
NCT06821711 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2
NCT01058057 ·Status: UNKNOWN ·Phase: PHASE3
-
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
NCT06014060 ·Status: RECRUITING ·Phase: NA
-
Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects
NCT00725829 ·Status: UNKNOWN ·Phase: NA
-
Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination
NCT03393377 ·Status: COMPLETED ·Phase: NA
-
Influence of Lipid Lowering on Impaired Coronary Flow
NCT05368545 ·Status: COMPLETED ·Phase: NA